| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 107 |
| 1 | METHOTREXATE | 89 |
| 2 | ETANERCEPT | 57 |
| 3 | ADALIMUMAB | 53 |
| 4 | ASPIRIN | 47 |
| 5 | ASPIRIN 325 MG | 43 |
| 6 | ASPIRIN 81 MG | 43 |
| 7 | FOLIC ACID | 41 |
| 8 | CARBOPLATIN | 39 |
| 9 | PREDNISOLONE | 39 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BARICITINIB | 8 | 0.0026 |
| 1 | GOLIMUMAB | 19 | 0.0015 |
| 2 | FINGOLIMOD HYDROCHLORIDE | 7 | 0.0014 |
| 3 | TOLVAPTAN | 13 | 0.0009 |
| 4 | CRIZOTINIB | 11 | 0.0009 |
| 5 | CANDESARTAN | 20 | 0.0006 |
| 6 | EVEROLIMUS TABLETS | 8 | 0.0005 |
| 7 | IPRATROPIUM BROMIDE | 15 | 0.0004 |
| 8 | PEMETREXED DISODIUM | 15 | 0.0004 |
| 9 | ALEMTUZUMAB | 7 | 0.0004 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 106 |
| 1 | Tumor Necrosis Factor Blocker [EPC] | 103 |
| 2 | Folate Analog Metabolic Inhibitor [EPC] | 98 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 85 |
| 4 | Kinase Inhibitor [EPC] | 57 |
| 5 | Platelet Aggregation Inhibitor [EPC] | 47 |
| 6 | Platinum-based Drug [EPC] | 45 |
| 7 | Vitamin B12 [EPC] | 42 |
| 8 | Vitamin C [EPC] | 42 |
| 9 | Vitamin D [EPC] | 41 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Blood Viscosity Reducer [EPC] | 6 | 0.0014 |
| 1 | Vasopressin V2 Receptor Antagonist [EPC] | 13 | 0.0009 |
| 2 | CD38-directed Cytolytic Antibody [EPC] | 3 | 0.0005 |
| 3 | Sphingosine 1-phosphate Receptor Modulator [EPC] | 7 | 0.0005 |
| 4 | Selective T Cell Costimulation Blocker [EPC] | 2 | 0.0004 |
| 5 | CD52-directed Cytolytic Antibody [EPC] | 7 | 0.0004 |
| 6 | Calcitonin [EPC] | 1 | 0.0003 |
| 7 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 30 | 0.0003 |
| 8 | Adenosine Triphosphate-Citrate Lyase Inhibitor [EPC] | 1 | 0.0003 |
| 9 | Thymic Stromal Lymphopoietin Blocker [EPC] | 2 | 0.0003 |